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Abstract 
 
Hyperglycaemia is the medical term for a state caused by a high level of 
blood glucose, resulting from defects in insulin secretion, insulin action, or both. 
Hyperglycaemia is a common dangerous complication to glycaemic control in Type 
1 diabetic patients. The chronic hyperglycaemia of diabetes is associated with long-
term damage, dysfunction, and failure of different organs, especially the eyes, 
kidneys, nerves, heart, and blood vessels. Therefore, reliable detection of 
hyperglycaemic episodes is important in order to avoid major health conditions.  
 Conventionally, diabetic patients need to frequently monitor blood glucose 
levels to determine whether they have hyperglycaemia or not. A patient has to prick 
their finger (finger-stick) for a drop of blood several times a day, which can therefore 
significantly discourage many patients from periodically checking blood glucose 
levels. Another choice for hyperglycaemia detection might be continuous glucose 
monitoring systems (CGMS), which measure the glucose level in the interstitial fluid. 
For patients using CGMS, finger-sticks are still required to calibrate the sensor. The 
main shortcoming of CGMS is that glucose levels in interstitial fluid lag temporally 
behind blood glucose values, normally 10-15 minutes, which absolutely limits the 
accuracy of the detection. There is a strong demand to have a non-invasive technique 
to help patients to diagnose the disease easily and painlessly. Few methods have been 
reported to detect hyperglycaemia non-invasively or minimally invasively such as in 
exhaled methyl nitrates, and early detection of ongoing β cell death. However, the 
purpose of these studies was on real-time glucose control rather than disease 
diagnosis. 
Electrocardiography (ECG) is a broadly used technique to obtain a quick, 
non-invasive clinical and research screen for diagnosing abnormal rhythms of the 
heart caused by diseases. In fact, observations of ECG changes have been found in 
hypoglycaemia and hyperglycaemia states in T1DM, such as increased heart rate and 
prolongation of QT interval in hypoglycaemia, whereas hyperglycaemia was related 
to reduced heart rate variability. By using these findings in hypoglycaemia, 
 xviii 
 
researchers have developed an effective and sensitive system to detect 
hypoglycaemia non-invasively. These excellent performances of hypoglycaemia 
detection using ECG is the motivation of this thesis to study the effect of 
hyperglycaemia on ECG signals, and based on the findings to exploit the 
computational intelligence on the non-invasive detection of hyperglycaemia. 
This research firstly explores the changes of ECG parameters associated with 
the hyperglycaemic state in T1DM. The ECG parameters consist of ECG intervals 
relating to repolarisation phase and heart rate variability (HRV) measures. A clinical 
study of ten T1DM patients and ECG feature extraction process are conducted to 
collect ECG features. Statistical analysis is then applied to every ECG feature to 
estimate the significant difference between hyperglycaemic and normoglycaemic 
states. The results show that the selected ECG parameters in hyperglycaemia differ 
significantly from those in normoglycaemia (p< 0.05). It implies that certain ECG 
parameters are correlated with high blood glucose levels and they possibly contribute 
to the performance of hyperglycaemia detection. Thus, the ECG parameters are used 
for input data of hyperglycaemia classifiers in this thesis. 
 Furthermore, the thesis introduces novel computational intelligent methods 
for hyperglycaemia detection using the ECG parameters. A neural network using 
Levenberg-Marquardt algorithm is the first method explored for hyperglycaemia 
detection in this thesis, known as LM-NN. The second algorithm is the integration of 
principal component analysis (PCA) with a neural network utilising the Levenberg-
Marquardt algorithm, which is called a PCA-LM-NN network. PCA is a useful tool 
for dimensionality reduction to diminish the computational requirement and 
overcome the problem of multicollinearity. It is employed to filter the data so that 
only the significant independent ECG variables responsible for the high blood 
glucose levels can be used as input for the network training, in order that the neural 
network performs well for hyperglycaemia detection. The third method is for the 
improvement of the second method where particle swarm optimization is included. 
This algorithm is a combination of PCA, PSO and neural network, which is called 
PSO-NN. The PSO is utilised as an effective training algorithm to optimise the 
weights of the neural network. The proposed methods are compared with each other 
 xix 
 
and with other traditional classifiers. All the algorithms are investigated with the 
clinical electrocardiographic data extracted from ten T1DM patients.  
The results show that the performance of PCA-LM model for hyperglycaemia 
detection is better than that of LM-NN (70.88% vs. 67.94%, in terms of geometric 
mean). In addition, the PSO-NN outperforms the PCA-LM-NN (77.58% vs. 70.88%, 
in terms of geometric mean). In short, the PSO-NN significantly improves the 
performances of both the LM-NN and PCA-LM-NN, with considerable sensitivity, 
specificity and geometric mean of 82.35%, 73.08% and 77.58%, respectively.   
 
 
